Franklin Resources Inc. Purchases 77,027 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Franklin Resources Inc. boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 273.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 105,228 shares of the company’s stock after buying an additional 77,027 shares during the period. Franklin Resources Inc.’s holdings in Acadia Healthcare were worth $6,673,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. GAMMA Investing LLC lifted its stake in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the period. Commonwealth Equity Services LLC increased its holdings in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares in the last quarter. Atria Investments Inc lifted its stake in Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the period. KBC Group NV boosted its holdings in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after buying an additional 338 shares in the last quarter. Finally, Tidal Investments LLC grew its position in shares of Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares during the period.

Acadia Healthcare Stock Down 1.8 %

ACHC stock opened at $37.90 on Monday. The firm has a market capitalization of $3.52 billion, a PE ratio of 12.43, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The stock’s 50 day moving average is $43.80 and its 200-day moving average is $60.81.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period last year, the business earned $0.91 EPS. The business’s revenue was up 8.7% on a year-over-year basis. Sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.